Skip to main content
. 2023 Apr 3;17:1132179. doi: 10.3389/fnins.2023.1132179

Figure 2.

Figure 2

Summary of therapeutic strategies for retinal dystrophy (RD) associated with rhodopsin mutations. The strategies include whole-eye electric stimulation, pharmacological therapy (flavonoids, vitamin A, small molecular chaperones, 4-PBA (4-phenyl butyric acid), and rolipram), ASO (antisense oligonucleotide) therapy, gene therapy, neuroprotection, optogenetic therapy, and stem cell therapy (including photoreceptor regeneration from Müller cells).